Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
Antigen modulation therapies for cancer and autoimmune disease
Grey Wolf Therapeutics is a clinical-stage biotechnology company developing small molecule inhibitors of endoplasmic reticulum aminopeptidases (ERAP1 and ERAP2) to modulate…
Nonclinical safety toxicology and ion channel screening services
ApconiX is a nonclinical safety consultancy and ion channel laboratory supporting drug discovery and development programmes. The company provides project toxicology, DMPK support,…
Small molecule regulators of mitochondrial transfer for age related disease
Nascent Therapeutics is a biotechnology company developing small molecule therapies that regulate mitochondrial transfer between cells. The company's discovery platform identifies…
Custom radiolabelling and integrated small molecule drug discovery services
Eurofins Selcia is a contract research organisation specialising in custom carbon-14 and stable isotope radiolabelling, GMP radiolabelled API manufacturing, and integrated small…
Virus-like particle therapeutics for chronic inflammatory skin conditions
Glen Clova Scientific is a biotechnology company developing active biologic drugs for chronic inflammatory and autoimmune disorders, with an initial focus on immuno-dermatology.…
Microfluidic instruments for protein interaction and single-cell analysis
Fluidic Sciences is a company developing and supplying instruments for biopharmaceutical research, combining two complementary technology platforms. Its core offering covers…
Novel antibiotic-sparing therapeutics for chronic wound care
ONYA Therapeutics is a biotechnology company developing novel pharmaceutical treatments for acute and chronic wounds. The company's pipeline centres on a patented…
Integrated CRO services from drug discovery to manufacture
Charles River Laboratories is a global contract research organisation providing integrated preclinical drug discovery and development services to pharmaceutical, biotechnology and…
DNA nanoprobes for intracellular biomarker profiling in neurodegeneration
Esya Labs is a precision biomarker company using patented DNA nanoprobes to measure ion signatures within intracellular organelles including endosomes and lysosomes. The…
ADC oncology company developing novel spliceosome-modulating payloads
Akari Therapeutics is a clinical-stage biopharma company developing next-generation bi-functional antibody-drug conjugates for cancer treatment. Its proprietary ADC platform…
Immunotherapeutics targeting drug-resistant bacterial infections
Centauri Therapeutics is a clinical-stage immunotherapy company developing treatments for life-threatening infectious diseases using its proprietary platform. The technology uses…
AI-ready toxicity datasets for preclinical drug discovery
Biolligence is a biotechnology company developing AI-ready toxicity datasets and predictive tools for the drug discovery industry. The company combines deep learning algorithms…